Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
36.46
+0.60 (1.67%)
At close: Aug 13, 2025, 4:00 PM
36.75
+0.29 (0.80%)
After-hours: Aug 13, 2025, 7:56 PM EDT
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of $21.26 billion as of August 13, 2025. Its market cap has increased by 63.35% in one year.
Market Cap
21.26B
Enterprise Value
28.64B
1-Year Change
63.35%
Ranking
Category
Stock Price
$36.46
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has increased from $15.76B to $21.26B, an increase of 34.91%. That is a compound annual growth rate of 5.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 15.50B | 36.77% |
| Dec 31, 2024 | 11.33B | -9.30% |
| Dec 29, 2023 | 12.50B | -28.31% |
| Dec 30, 2022 | 17.43B | 1.85% |
| Dec 31, 2021 | 17.12B | -11.89% |
| Dec 31, 2020 | 19.43B | 23.26% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 570.26B |
| Johnson & Johnson | 418.62B |
| AbbVie | 350.91B |
| AstraZeneca | 229.47B |
| UnitedHealth Group | 228.94B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 228.63B |
| Novo Nordisk | 222.88B |